Please assess the completion status of the following clinical trial:

Trial Title: Study of South African Dialysis Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients undergoing chronic haemodialysis or peritoneal dialysis~* Commenced Aranesp therapy 3-6 months prior to enrolment~* Erythropoiesis stimulating agent (ESA) naive or treated with another ESA prior to commencing Aranesp~* Informed consent obtained~Exclusion Criteria:~* Received Aranesp in an interventional study within 6 months prior to start of observation period~* Receive investigational product during the observation period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Study population (Type: None): Single cohort of dialysis patients

Based on this trial design, predict the completion outcome and termination type (if applicable).